Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with c... Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.4 | 3.04414003044 | 13.14 | 14.16 | 13.03 | 817033 | 13.51860859 | CS |
| 4 | -0.93 | -6.42709053214 | 14.47 | 16.76 | 12.8631 | 1312960 | 14.63362843 | CS |
| 12 | -0.25 | -1.81290790428 | 13.79 | 16.76 | 12.8631 | 1081394 | 14.36165509 | CS |
| 26 | -0.26 | -1.88405797101 | 13.8 | 16.76 | 11.94 | 1021800 | 14.19011539 | CS |
| 52 | 1.39 | 11.4403292181 | 12.15 | 18.0699 | 11.3 | 916627 | 14.57877736 | CS |
| 156 | -4.05 | -23.0244457078 | 17.59 | 28.3499 | 5.44 | 829930 | 15.10994288 | CS |
| 260 | -11.46 | -45.84 | 25 | 28.699 | 5.44 | 727091 | 15.29242113 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
